Lexaria Bioscience Receives Ethics Approval for Human Pilot Study
Lexaria Bioscience (LEXX) announces that ethics approval has been received from an independent review board, for Human Pilot Study #7 that will evaluate two oral DehydraTECH-semaglutide compositions against Novo Nordisk's (NVO) commercially available Wegovy tablets.
